Cargando…
Molecular targets in acromegaly
Molecular therapeutic targets in growth hormone (GH)-secreting adenomas range from well-characterized surface receptors that recognize approved drugs, to surface and intracellular markers that are potential candidates for new drug development. Currently available medical therapies for patients with...
Autores principales: | Labadzhyan, Artak, Melmed, Shlomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760705/ https://www.ncbi.nlm.nih.gov/pubmed/36545335 http://dx.doi.org/10.3389/fendo.2022.1068061 |
Ejemplares similares
-
Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide
por: Samson, Susan L, et al.
Publicado: (2020) -
MON-314 Analysis of Adverse Events in Adult Patients with Acromegaly Receiving Oral Octreotide Capsules: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study
por: Labadzhyan, Artak, et al.
Publicado: (2020) -
The acromegaly lipodystrophy
por: Freda, Pamela U.
Publicado: (2022) -
The Endothelium in Acromegaly
por: Maffei, Pietro, et al.
Publicado: (2019) -
Colonic Cancer and Acromegaly
por: Dworakowska, Dorota, et al.
Publicado: (2019)